Company / Free Cash Flow per Share
REGENXBIO Inc. Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$2.55
FY2025
5-year range
-$5.56 / -$2.55
FY2021-FY2025
Trend
+36.0%
vs FY2024
Sector context
#145 of 192
Health Care
What the data says
REGENXBIO Inc.'s free cash flow per share of $-2.55 is lower than 76% of companies in the Health Care sector (FY2025). Free Cash Flow per Share has increased for 3 consecutive years, from $-5.56 in FY2022 to $-2.55 in FY2025.
Based on SEC 10-K filings.
-2.55 in FY2025.
Improved from $-5.27 to $-2.55 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 24% in Health CareTop 76% of 192This company -$2.55 Sector average $3.32
▼
-176.9% below sector average
Key checks
Key Insights
- REGENXBIO Inc.'s free cash flow per share has grown for 3 consecutive years.
- In FY2025, free cash flow per share increased 36.0% year-over-year.
- Ranks #145 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score -2.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.55 | +36.0% |
| FY2024 | -$3.99 | +24.4% |
| FY2023 | -$5.27 | +5.2% |
| FY2022 | -$5.56 | -74.5% |
| FY2021 | -$3.19 | -229.0% |
| FY2020 | $2.47 | +236.9% |
| FY2019 | -$1.80 | -161.8% |
| FY2018 | $2.92 | +218.7% |
| FY2017 | -$2.46 | -2116.7% |
| FY2016 | -$0.11 | +91.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026